NuCana BioMed's IPO

NuCana BioMed raised a round of funding on September 28, 2017. Investors include Public.

NuCana is a clinical stage biopharmaceutical company developing and commercialising novel anti-cancer medicines. With its next generation of anti-cancer agents (nucleotide analogues), NuCana is settin…

Articles about NuCana BioMed's IPO: